Global Soliris (Eculizumab) Market Growth (Status and Outlook) 2020-2025
According to this study, over the next five years the Soliris (Eculizumab) market will register a xx%% CAGR in terms of revenue, the global market size will reach $ xx million by 2025, from $ xx million in 2019. In particular, this report presents the global revenue market share of key companies in Soliris (Eculizumab) business, shared in Chapter 3.
This report presents a comprehensive overview, market shares, and growth opportunities of Soliris (Eculizumab) market by product type, application, key manufacturers and key regions and countries.
This study specially analyses the impact of Covid-19 outbreak on the Soliris (Eculizumab), covering the supply chain analysis, impact assessment to the Soliris (Eculizumab) market size growth rate in several scenarios, and the measures to be undertaken by Soliris (Eculizumab) companies in response to the COVID-19 epidemic.
Segmentation by type: breakdown data from 2015 to 2020 in Section 2.3; and forecast to 2025 in section 10.7.
Plasma Exchange
Plasma Infusion
Segmentation by application: breakdown data from 2015 to 2020, in Section 2.4; and forecast to 2025 in section 10.8.
PNH
aHUS
Other
This report also splits the market by region: Breakdown data in Chapter 4, 5, 6, 7 and 8.
Americas
United States
Canada
Mexico
Brazil
APAC
China
Japan
Korea
Southeast Asia
India
Australia
Europe
Germany
France
UK
Italy
Russia
Middle East & Africa
Egypt
South Africa
Israel
Turkey
GCC Countries
The report also presents the market competition landscape and a corresponding detailed analysis of the major vendor/manufacturers in the market. The key manufacturers covered in this report: Breakdown data in in Chapter 3.
Alexion
...
In addition, this report discusses the key drivers influencing market growth, opportunities, the challenges and the risks faced by key players and the market as a whole. It also analyzes key emerging trends and their impact on present and future development.
Research objectives
To study and analyze the global Soliris (Eculizumab) market size by key regions/countries, type and application, history data from 2015 to 2019, and forecast to 2025.
To understand the structure of Soliris (Eculizumab) market by identifying its various subsegments.
Focuses on the key global Soliris (Eculizumab) players, to define, describe and analyze the value, market share, market competition landscape, SWOT analysis and development plans in next few years.
To analyze the Soliris (Eculizumab) with respect to individual growth trends, future prospects, and their contribution to the total market.
To share detailed information about the key factors influencing the growth of the market (growth potential, opportunities, drivers, industry-specific challenges and risks).
To project the size of Soliris (Eculizumab) submarkets, with respect to key regions (along with their respective key countries).
To analyze competitive developments such as expansions, agreements, new product launches and acquisitions in the market.
To strategically profile the key players and comprehensively analyze their growth strategies.
Frequently Asked Questions
The base year for the study has been considered 2019, historic year 2014 and 2018, the forecast period considered is from 2020 to 2027. The regions analyzed for the market include North America, Europe, South America, Asia Pacific, and Middle East and Africa. These regions are further analyzed at the country-level. The study also includes attractiveness analysis of type, application and regions which are benchmarked based on their market size, growth rate and attractiveness in terms of present and future opportunity for understanding the future growth of the market.
Market is segmented on the basis:
- By Type
- By Application
- By Region
- By Country
- By Manufacturer
The report offers in-depth analysis of driving factors, opportunities, restraints, and challenges for gaining the key insight of the market. The report emphasizes on all the key trends that play a vital role in the enlargement of the market from 2019 to 2026.
The report provides company profile of the key players operating in the market and a comparative analysis based on their business overviews industry offering, segment market share, regional presence, business strategies, innovations, mergers & acquisitions, recent developments, joint venture, collaborations, partnerships, SWOT analysis, and key financial information.
1 Scope of the Report
1.1 Market Introduction
1.2 Research Objectives
1.3 Years Considered
1.4 Market Research Methodology
1.5 Economic Indicators
1.6 Currency Considered
2 Executive Summary
2.1 World Market Overview
2.1.1 Global Soliris (Eculizumab) Market Size 2015-2025
2.1.2 Soliris (Eculizumab) Market Size CAGR by Region
2.2 Soliris (Eculizumab) Segment by Type
2.2.1 Plasma Exchange
2.2.2 Plasma Exchange
2.3 Soliris (Eculizumab) Market Size by Type
2.3.1 Global Soliris (Eculizumab) Market Size Market Share by Type (2015-2020)
2.3.2 Global Soliris (Eculizumab) Market Size Growth Rate by Type (2015-2020)
2.4 Soliris (Eculizumab) Segment by Application
2.4.1 PNH
2.4.2 aHUS
2.4.3 Other
2.5 Soliris (Eculizumab) Market Size by Application
2.5.1 Global Soliris (Eculizumab) Market Size Market Share by Application (2015-2020)
2.5.2 Global Soliris (Eculizumab) Market Size Growth Rate by Application (2015-2020)
3 Global Soliris (Eculizumab) by Players
3.1 Global Soliris (Eculizumab) Market Size Market Share by Players
3.1.1 Global Soliris (Eculizumab) Market Size by Players (2018-2020)
3.1.2 Global Soliris (Eculizumab) Market Size Market Share by Players (2018-2020)
3.2 Global Soliris (Eculizumab) Key Players Head office and Products Offered
3.3 Market Concentration Rate Analysis
3.3.1 Competition Landscape Analysis
3.3.2 Concentration Ratio (CR3, CR5 and CR10) (2018-2020)
3.4 New Products and Potential Entrants
3.5 Mergers & Acquisitions, Expansion
4 Soliris (Eculizumab) by Regions
4.1 Soliris (Eculizumab) Market Size by Regions
4.2 Americas Soliris (Eculizumab) Market Size Growth
4.3 APAC Soliris (Eculizumab) Market Size Growth
4.4 Europe Soliris (Eculizumab) Market Size Growth
4.5 Middle East & Africa Soliris (Eculizumab) Market Size Growth
5 Americas
5.1 Americas Soliris (Eculizumab) Market Size by Countries
5.2 Americas Soliris (Eculizumab) Market Size by Type
5.3 Americas Soliris (Eculizumab) Market Size by Application
5.4 United States
5.5 Canada
5.6 Mexico
5.7 Key Economic Indicators of Few Americas Countries
6 APAC
6.1 APAC Soliris (Eculizumab) Market Size by Regions
6.2 APAC Soliris (Eculizumab) Market Size by Type
6.3 APAC Soliris (Eculizumab) Market Size by Application
6.4 China
6.5 Japan
6.6 Korea
6.7 Southeast Asia
6.8 India
6.9 Australia
6.10 Key Economic Indicators of Few APAC Regions
7 Europe
7.1 Europe Soliris (Eculizumab) by Countries
7.2 Europe Soliris (Eculizumab) Market Size by Type
7.3 Europe Soliris (Eculizumab) Market Size by Application
7.4 Germany
7.5 France
7.6 UK
7.7 Italy
7.8 Russia
7.9 Key Economic Indicators of Few Europe Countries
8 Middle East & Africa
8.1 Middle East & Africa Soliris (Eculizumab) by Countries
8.2 Middle East & Africa Soliris (Eculizumab) Market Size by Type
8.3 Middle East & Africa Soliris (Eculizumab) Market Size by Application
8.4 Egypt
8.5 South Africa
8.6 Israel
8.7 Turkey
8.8 GCC Countries
9 Market Drivers, Challenges and Trends
9.1 Market Drivers and Impact
9.1.1 Growing Demand from Key Regions
9.1.2 Growing Demand from Key Applications and Potential Industries
9.2 Market Challenges and Impact
9.3 Market Trends
10 Global Soliris (Eculizumab) Market Forecast
10.1 Global Soliris (Eculizumab) Market Size Forecast (2021-2025)
10.2 Global Soliris (Eculizumab) Forecast by Regions
10.2.1 Global Soliris (Eculizumab) Forecast by Regions (2021-2025)
10.2.2 Americas Market Forecast
10.2.3 APAC Market Forecast
10.2.4 Europe Market Forecast
10.2.5 Middle East & Africa Market Forecast
10.3 Americas Forecast by Countries
10.3.1 United States Market Forecast
10.3.2 Canada Market Forecast
10.3.3 Mexico Market Forecast
10.3.4 Brazil Market Forecast
10.4 APAC Forecast by Countries
10.4.1 China Market Forecast
10.4.2 Japan Market Forecast
10.4.3 Korea Market Forecast
10.4.4 Southeast Asia Market Forecast
10.4.5 India Market Forecast
10.4.6 Australia Market Forecast
10.5 Europe Forecast by Countries
10.5.1 Germany Market Forecast
10.5.2 France Market Forecast
10.5.3 UK Market Forecast
10.5.4 Italy Market Forecast
10.5.5 Russia Market Forecast
10.5.6 Spain Market Forecast
10.6 Middle East & Africa Forecast by Countries
10.6.1 Egypt Market Forecast
10.6.2 South Africa Market Forecast
10.6.3 Israel Market Forecast
10.6.4 Turkey Market Forecast
10.6.5 GCC Countries Market Forecast
10.7 Global Soliris (Eculizumab) Forecast by Type
10.8 Global Soliris (Eculizumab) Forecast by Application
11 Key Players Analysis
11.1 Alexion
11.1.1 Company Details
11.1.2 Soliris (Eculizumab) Product Offered
11.1.3 Alexion Soliris (Eculizumab) Revenue, Gross Margin and Market Share (2018-2020)
11.1.4 Main Business Overview
11.1.5 Alexion News
...
12 Research Findings and Conclusion
List of Tables
Table 1. Research Methodology
Table 2. Data Source
Table 3. Soliris (Eculizumab) Market Size CAGR by Region 2015-2025 ($ Millions)
Table 4. Major Players of Plasma Exchange
Table 5. Major Players of Plasma Infusion
Table 6. Soliris (Eculizumab) Market Size by Type (2014-2019) ($ Millions)
Table 7. Global Soliris (Eculizumab) Market Size Market Share by Type (2015-2020)
Table 8. Global Soliris (Eculizumab) Market Size by Application (2015-2020) ($ Millions)
Table 9. Global Soliris (Eculizumab) Market Size Market Share by Application (2015-2020)
Table 10. Global Soliris (Eculizumab) Revenue by Players (2018-2020) ($ Millions)
Table 11. Global Soliris (Eculizumab) Revenue Market Share by Players (2018-2020)
Table 12. Global Soliris (Eculizumab) Key Players Head office and Products Offered
Table 13. Soliris (Eculizumab) Concentration Ratio (CR3, CR5 and CR10) (2018-2020)
Table 14. New Products and Potential Entrants
Table 15. Mergers & Acquisitions, Expansion
Table 16. Global Soliris (Eculizumab) Market Size by Regions 2015-2020 ($ Millions)
Table 17. Global Soliris (Eculizumab) Market Size Market Share by Regions 2015-2020
Table 18. Americas Soliris (Eculizumab) Market Size by Countries (2015-2020) ($ Millions)
Table 19. Americas Soliris (Eculizumab) Market Size Market Share by Countries (2015-2020)
Table 20. Americas Soliris (Eculizumab) Market Size by Type (2015-2020) ($ Millions)
Table 21. Americas Soliris (Eculizumab) Market Size Market Share by Type (2015-2020)
Table 22. Americas Soliris (Eculizumab) Market Size by Application (2015-2020) ($ Millions)
Table 23. Americas Soliris (Eculizumab) Market Size Market Share by Application (2015-2020)
Table 24. APAC Soliris (Eculizumab) Market Size by Regions (2015-2020) ($ Millions)
Table 25. APAC Soliris (Eculizumab) Market Size Market Share by Regions (2015-2020)
Table 26. APAC Soliris (Eculizumab) Market Size by Type (2015-2020) ($ Millions)
Table 27. APAC Soliris (Eculizumab) Market Size Market Share by Type (2015-2020)
Table 28. APAC Soliris (Eculizumab) Market Size by Application (2015-2020) ($ Millions)
Table 29. APAC Soliris (Eculizumab) Market Size Market Share by Application (2015-2020)
Table 30. Europe Soliris (Eculizumab) Market Size by Countries (2015-2020) ($ Millions)
Table 31. Europe Soliris (Eculizumab) Market Size Market Share by Countries (2015-2020)
Table 32. Europe Soliris (Eculizumab) Market Size by Type (2015-2020) ($ Millions)
Table 33. Europe Soliris (Eculizumab) Market Size Market Share by Type (2015-2020)
Table 34. Europe Soliris (Eculizumab) Market Size by Application (2015-2020) ($ Millions)
Table 35. Europe Soliris (Eculizumab) Market Size Market Share by Application (2015-2020)
Table 36. Middle East & Africa Soliris (Eculizumab) Market Size by Countries (2015-2020) ($ Millions)
Table 37. Middle East & Africa Soliris (Eculizumab) Market Size Market Share by Countries (2015-2020)
Table 38. Middle East & Africa Soliris (Eculizumab) Market Size by Type (2015-2020) ($ Millions)
Table 39. Middle East & Africa Soliris (Eculizumab) Market Size Market Share by Type (2015-2020)
Table 40. Middle East & Africa Soliris (Eculizumab) Market Size by Application (2015-2020) ($ Millions)
Table 41. Middle East & Africa Soliris (Eculizumab) Market Size Market Share by Application (2015-2020)
Table 42. Key and Potential Regions of Soliris (Eculizumab)
Table 43. Key Application and Potential Industries of Soliris (Eculizumab)
Table 44. Key Challenges of Soliris (Eculizumab)
Table 45. Key Trends of Soliris (Eculizumab)
Table 46. Global Soliris (Eculizumab) Market Size Forecast by Regions (2021-2025) ($ Millions)
Table 47. Global Soliris (Eculizumab) Market Size Market Share Forecast by Regions
Table 48. Global Soliris (Eculizumab) Market Size Forecast by Type (2021-2025) ($ Millions)
Table 49. Global Soliris (Eculizumab) Market Size Market Share Forecast by Type (2021-2025)
Table 50. Global Soliris (Eculizumab) Market Size Forecast by Application (2021-2025) ($ Millions)
Table 51. Global Soliris (Eculizumab) Market Size Market Share Forecast by Application (2021-2025)
Table 52. Alexion Details, Company Total Revenue (in $ million), Head Office, Soliris (Eculizumab) Major Market Areas and Its Competitors
Table 53. Alexion Soliris (Eculizumab) Product Offered
Table 54. Alexion Soliris (Eculizumab) Revenue and Gross Margin (2018-2020E)
Table 55. Alexion Main Business
Table 56. Alexion Latest Developments
List of Figures
Figure 1. Soliris (Eculizumab) Report Years Considered
Figure 2. Market Research Methodology
Figure 3. Global Soliris (Eculizumab) Market Size Growth Rate 2015-2025 ($ Millions)
Figure 4. Global Soliris (Eculizumab) Market Size Market Share by Type (2015-2020)
Figure 5. Global Plasma Exchange Market Size Growth Rate
Figure 6. Global Plasma Infusion Market Size Growth Rate
Figure 7. Soliris (Eculizumab) in PNH
Figure 8. Global Soliris (Eculizumab) Market: PNH (2015-2020) ($ Millions)
Figure 9. Soliris (Eculizumab) in aHUS
Figure 10. Global Soliris (Eculizumab) Market: aHUS (2015-2020) ($ Millions)
Figure 11. Soliris (Eculizumab) in Other
Figure 12. Global Soliris (Eculizumab) Market: Other (2015-2020) ($ Millions)
Figure 13. Global Other YoY Growth ($ Millions)
Figure 14. Global Soliris (Eculizumab) Market Size Market Share by Application in 2019
Figure 15. Global Soliris (Eculizumab) Market Size Market Share by Regions 2015-2020
Figure 16. Americas Soliris (Eculizumab) Market Size 2015-2020 ($ Millions)
Figure 17. APAC Soliris (Eculizumab) Market Size 2015-2020 ($ Millions)
Figure 18. Europe Soliris (Eculizumab) Market Size 2015-2020 ($ Millions)
Figure 19. Middle East & Africa Soliris (Eculizumab) Market Size 2015-2020 ($ Millions)
Figure 20. Americas Soliris (Eculizumab) Market Size Market Share by Countries in 2019
Figure 21. Americas Soliris (Eculizumab) Market Size Market Share by Type in 2019
Figure 22. Americas Soliris (Eculizumab) Market Size Market Share by Application in 2019
Figure 23. United States Soliris (Eculizumab) Market Size Growth 2015-2020 ($ Millions)
Figure 24. Canada Soliris (Eculizumab) Market Size Growth 2015-2020 ($ Millions)
Figure 25. Mexico Soliris (Eculizumab) Market Size Growth 2015-2020 ($ Millions)
Figure 26. APAC Soliris (Eculizumab) Market Size Market Share by Regions in 2019
Figure 27. APAC Soliris (Eculizumab) Market Size Market Share by Type in 2019
Figure 28. APAC Soliris (Eculizumab) Market Size Market Share by Application in 2019
Figure 29. China Soliris (Eculizumab) Market Size Growth 2015-2020 ($ Millions)
Figure 30. Japan Soliris (Eculizumab) Market Size Growth 2015-2020 ($ Millions)
Figure 31. Korea Soliris (Eculizumab) Market Size Growth 2015-2020 ($ Millions)
Figure 32. Southeast Asia Soliris (Eculizumab) Market Size Growth 2015-2020 ($ Millions)
Figure 33. India Soliris (Eculizumab) Market Size Growth 2015-2020 ($ Millions)
Figure 34. Australia Soliris (Eculizumab) Market Size Growth 2015-2020 ($ Millions)
Figure 35. Europe Soliris (Eculizumab) Market Size Market Share by Countries in 2019
Figure 36. Europe Soliris (Eculizumab) Market Size Market Share by Type in 2019
Figure 37. Europe Soliris (Eculizumab) Market Size Market Share by Application in 2019
Figure 38. Germany Soliris (Eculizumab) Market Size Growth 2015-2020 ($ Millions)
Figure 39. France Soliris (Eculizumab) Market Size Growth 2015-2020 ($ Millions)
Figure 40. UK Soliris (Eculizumab) Market Size Growth 2015-2020 ($ Millions)
Figure 41. Italy Soliris (Eculizumab) Market Size Growth 2015-2020 ($ Millions)
Figure 42. Russia Soliris (Eculizumab) Market Size Growth 2015-2020 ($ Millions)
Figure 43. Spain Soliris (Eculizumab) Market Size Growth 2015-2020 ($ Millions)
Figure 44. Middle East & Africa Soliris (Eculizumab) Market Size Market Share by Countries in 2019
Figure 45. Middle East & Africa Soliris (Eculizumab) Market Size Market Share by Type in 2019
Figure 46. Middle East & Africa Soliris (Eculizumab) Market Size Market Share by Application in 2019
Figure 47. Egypt Soliris (Eculizumab) Market Size Growth 2015-2020 ($ Millions)
Figure 48. South Africa Soliris (Eculizumab) Market Size Growth 2015-2020 ($ Millions)
Figure 49. Israel Soliris (Eculizumab) Market Size Growth 2015-2020 ($ Millions)
Figure 50. Turkey Soliris (Eculizumab) Market Size Growth 2015-2020 ($ Millions)
Figure 51. GCC Countries Soliris (Eculizumab) Market Size Growth 2015-2020 ($ Millions)
Figure 52. Global Soliris (Eculizumab) arket Size Forecast (2021-2025) ($ Millions)
Figure 53. Americas Soliris (Eculizumab) Market Size 2021-2025 ($ Millions)
Figure 54. APAC Soliris (Eculizumab) Market Size 2021-2025 ($ Millions)
Figure 55. Europe Soliris (Eculizumab) Market Size 2021-2025 ($ Millions)
Figure 56. Middle East & Africa Soliris (Eculizumab) Market Size 2021-2025 ($ Millions)
Figure 57. United States Soliris (Eculizumab) Market Size 2021-2025 ($ Millions)
Figure 58. Canada Soliris (Eculizumab) Market Size 2021-2025 ($ Millions)
Figure 59. Mexico Soliris (Eculizumab) Market Size 2021-2025 ($ Millions)
Figure 60. Brazil Soliris (Eculizumab) Market Size 2021-2025 ($ Millions)
Figure 61. China Soliris (Eculizumab) Market Size 2021-2025 ($ Millions)
Figure 62. Japan Soliris (Eculizumab) Market Size 2021-2025 ($ Millions)
Figure 63. Korea Soliris (Eculizumab) Market Size 2021-2025 ($ Millions)
Figure 64. Southeast Asia Soliris (Eculizumab) Market Size 2021-2025 ($ Millions)
Figure 65. India Soliris (Eculizumab) Market Size 2021-2025 ($ Millions)
Figure 66. Australia Soliris (Eculizumab) Market Size 2021-2025 ($ Millions)
Figure 67. Germany Soliris (Eculizumab) Market Size 2021-2025 ($ Millions)
Figure 68. France Soliris (Eculizumab) Market Size 2021-2025 ($ Millions)
Figure 69. UK Soliris (Eculizumab) Market Size 2021-2025 ($ Millions)
Figure 70. Italy Soliris (Eculizumab) Market Size 2021-2025 ($ Millions)
Figure 71. Russia Soliris (Eculizumab) Market Size 2021-2025 ($ Millions)
Figure 72. Spain Soliris (Eculizumab) Market Size 2021-2025 ($ Millions)
Figure 73. Egypt Soliris (Eculizumab) Market Size 2021-2025 ($ Millions)
Figure 74. South Africa Soliris (Eculizumab) Market Size 2021-2025 ($ Millions)
Figure 75. Israel Soliris (Eculizumab) Market Size 2021-2025 ($ Millions)
Figure 76. Turkey Soliris (Eculizumab) Market Size 2021-2025 ($ Millions)
Figure 77. GCC Countries Soliris (Eculizumab) Market Size 2021-2025 ($ Millions)
